ACTIVE_NOT_RECRUITING

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to evaluate the surgical outcomes of injecting platelet-rich plasma (PRP) into the vaginal tissue as an adjunct therapy at the time of prolapse surgery

Official Title

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Quick Facts

Study Start:2023-07-01

Study Completion:2028-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05731284

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Desire surgical treatment via a transvaginal native tissue approach. * Completed child-bearing	* Unable to follow-up, not willing to, or unable to participate in the proposed study * Prior pelvic surgery within the past 12 months * Prior anterior/apical suspension procedures * Prior graft augmented prolapse surgery * Pelvic/abdominal radiation * Pelvic mass * History of solid organ malignancy

Contacts and Locations

Principal Investigator

Isuzu Meyer, MD, MSPH

PRINCIPAL_INVESTIGATOR

The University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham

Birmingham, Alabama, 35249

United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

Isuzu Meyer, MD, MSPH, PRINCIPAL_INVESTIGATOR, The University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-01

Study Completion Date2028-12-31

Study Record Updates

Study Start Date2023-07-01

Study Completion Date2028-12-31

Terms related to this study

Additional Relevant MeSH Terms

Pelvic Organ Prolapse